Hackensack Meridian Hackensack University Medical Center’s John Theurer Cancer Center established a satellite phase I clinical trial program at Jersey Shore University Medical Center, providing patients access to novel drugs or combinations of drugs for those in need of new options.
David Wheeler, member of the Cancer Prevention and Control research program at VCU Massey Cancer Center, was awarded a five-year, $1.7 million R01 grant from NCI to study thelong-term effects of neighborhood exposures and racial segregation on cancer risk through the use of innovative statistical models and analysis.
ChristianaCare received a $1 million gift from the Bacchieri Family to support the purchase of a state-of-the-art radiography system to analyze breast cancer specimens at the Helen F. Graham Cancer Center & Research Institute and expand a fellowship program to reduce disparities in breast and lung cancer.
The Medicaid expansion under the Patient Protection and Affordable Care Act resulted in a 19% annual increase in Medicaid-insured cancer patients participating in publicly funded clinical trials, according to researchers from Fred Hutchinson Cancer Center, the SWOG Statistics and Data Management Center and Columbia University.
Patients with cancer who live in rural Pennsylvania counties appear to know that they may have better outcomes if they receive their cancer surgery at a hospital that performs a high volume of those surgeries, but still opt for lower volume hospitals closer to home when their cancer is likely less complex, according to an analysis by health policy scientists at the University of Pittsburgh School of Public Health.
Rural women with cancer often receive financial support from within their communities and from formal organizations, but not all patients have equal access to this assistance, according to a study conducted by researchers at the University of Arkansas for Medical Sciences Office of Community Health & Research.
A “weighted” lottery program designed to ensure that people living in the most disadvantaged U.S. neighborhoods would be offered a scarce, potentially life-saving medication proved feasible in a large health system. The approach can improve equity in receipt of the drug by people disproportionately affected by disease, according to an analysis published today in JAMA Health Forum by University of Pittsburgh and UPMC scientist-clinicians.
Scientists at City of Hope have identified a cell metabolism process found in men with diabetes and metastatic prostate cancer that could one day lead to improved testing and treatments for Black men with these diseases.
More than 500 legislative proposals in 49 states are targeting trans people—predominantly youths—prompting fear among patients, healthcare providers, advocates, and legal experts that trans and gender nonconforming patients will be excluded from care.
At a glance, the 2023-24 U.S. News & World Report ranking for Best Hospitals for Cancer looks the way it always has—a list of premier institutions. You have to dig deeper to find changes in the way the closely watched 40-year-old ranking was put together and why these changes in methodology were made.
